Urinary tract infection (UTI) is one of the most common bacterial infection in women and responsible for significant morbidity and health care costs. It is a common problem in pregnancy due to morphological and physiological changes that takes place in genito-urinary tract during pregnancy. Asymptomatic bacteriuria (ASB) is the presence of actively multiplying bacteriuria of more than 10 5 /ml of urine without any symptom. Escherichia coli is the primary urinary tract pathogen accounting for 74 to 90% of uncomplicated urinary tract infection. Other bacteria include Staphylococcus saprophyticus, Klebsiella spp, Proteus spp, Enterococcus spp and
INTRODUCTION
Urinary tract infection (UTI) is one of the most common bacterial infection in women and responsible for significant morbidity and health care costs. It is a common problem in pregnancy due to morphological and physiological changes that takes place in genito-urinary tract during pregnancy. Asymptomatic bacteriuria (ASB) is the presence of actively multiplying bacteriuria of more than 10 5 /ml of urine without any symptom. Escherichia coli is the primary urinary tract pathogen accounting for 74 to 90% of uncomplicated urinary tract infection. Other bacteria include
Staphylococcus saprophyticus, Klebsiella spp, Proteus spp, Enterococcus spp and
Enterobacter spp. [1] [2] [3] About 50% of all females experience at least one episode of UTI during their life time. Asymptomatic bacteriuria and urinary tract infections (UTI) have a higher prevalence during pregnancy and in very sexually active females. UTI is an infection that affects any part of the urinary tract from bladder to the kidney. Symptoms include frequent and/or painful urination, urgency, fever and flank pain. The urine may contain pus or blood. UTI is a risk factor for pyelonephritis, preterm delivery and miscarriage among pregnant women. 4, 5 Extended spectrum β-lactamases (ESBLs) are defined as β-lactamases capable of hydrolyzing oxyiminocephalosporins and are inhibited by β-lactamase inhibitors. The primary organism causing urinary tract infection (UTI) like Escherichia coli produce ESBLs. These enzymes are plasmid borne and confer multiple drug resistance, making urinary tract infections difficult to treat. Inappropriate and wide spread use of antibiotics has lead to emergence of resistance markers like production of Extended spectrum β-lactamases (ESBLs) and concomitant multidrug resistance (MDR). 6, 7 The aim of this study was to determine in-vitro antibiotic susceptibility among urine isolates of Escherichia coli and prevalence of resistance markers like ESBL production and MDR status in female patients to guide the clinicians in patient care.
METHODS
This is a retrospective study conducted in Department of Microbiology, Sarvodaya Hospital and Research Centre, Sector-8, Faridabad, Haryana, India. Urine samples of female patients received from Obstetrics and Gynecology dept for bacteriological culture and sensitivity testing from September'17 to February'18 were analyzed.
A total of 205 mid-stream urine samples collected in wide mouthed sterile container for aerobic culture and sensitivity were analyzed. Samples were processed within one hour of collection. For routine examination of urine (wet film preparation), 50 µl of well mixed uncentrifuged urine was taken on a slide with coverslip placed on it and viewed under high power objective of microscope. The presence of one pus cell per 7 high power field was considered as significant pyuria. For urine culture, 1µl of urine sample was inoculated on HiCrome UTI agar media and MacConkey agar media (HiMedia, Mumbai, India) using a standard loop of internal diameter 1.34mm (semiquantitative method). The plates were read after 24 hours of aerobic incubation at 370C. They were further incubated for another 24 hours before reported as negative. 8 A single organism of colony count > 1,00,000 cfu/ml was subjected to identification and antibiotic sensitivity testing by Automated system BD Phoenix 100 (Becton Dickinson). The Extended Spectrum β-Lactamase production is also detected by this automated system. Multidrug resistance (MDR) is defined as antibiotic resistance to one or more agent in each of three or more groups of antibiotics. 7 MDR status was evaluated by calculating the resistance to each drug group. Escherichia coli ATCC 25922, Pseudomonas aeruginosa ATCC 27853 and Staphylococcus aureus ATCC 29213 used as quality control.
RESULTS
A total of 205 urine samples received in Microbiology Lab from Obstetrics and Gynecology dept. for aerobic culture and sensitivity, out of which 47 (22.93%) samples yielded positive growth, whereas 158 (77.07%) samples yielded no growth (Figure 1 ). Among the 47 positive isolates the predominant gramnegative bacteria was Escherichia coli (76.60%) out of which 36.11% was ESBL producer and 63.89% was ESBL non-producer. This was followed by Klebsiella pneumoniae (4.25%), Pseudomonas aeruginosa and Proteus mirabilis (2.13% each). The predominant grampositive organism was Enterococcus faecalis (6.38%) followed by Staphylococcus saprophyticus and Staphylococcus haemolyticus (2.13% each). The percentage of Candida spp. was 4.25% (Table 1) . Whereas ESBL isolates also showed high resistance to these two drug groups (30.8% and 53.8% respectively).
Resistance to 8 and ≥9 drug groups are less (2.8% each). But there were 8 isolates (22.2%) which were sensitive to all the 11 drug groups and all of them were ESBL non-producers, which again constitutes 34.8% of all the ESBL non-producers (Table 5) .
DISCUSSION
Escherichia coli, an Enterobacteriaceae, is a normal intestinal flora and is the most commonly reported cause of UTI, being a common fecal contaminant. Due to short length of urethra in females and closeness of female anus and vagina to the urethra, the organism gets inoculated into the urethra during process of anal cleaning after defecation or during sexual intercourse.
Washing of genitals from back to front is more likely to lead to spread of anal or vaginal flora into urethra. Health education on the direction of washing and advice to micturate shortly after sexual activity can reduce the chances of getting UTI. If asymptomatic bacteriuria (ASB) is left undiagnosed, there is risk of developing acute pyelonephritis in pregnant women which is associated with preterm labour. Early diagnosis and treatment of ASB can reduce the incidence of pyelonephritis and prevent preterm labour.
3,4
The present study revealed Escherichia coli as the predominant isolate from urine samples of female patients, which well correlates with many studies. [3] [4] [5] [8] [9] [10] [11] [12] The age group wise distribution showed that Escherichia coli isolates were mostly prevalent in adult age group (21-40 years), which also correlates well with the studies conducted by Patnaik M et al, Oli A N et al and Arora G et al. 2, 4, 13 The antibiotic sensitivity pattern of Escherichia coli in this study showed very good sensitivity towards Amikacin, Tigecycline, Meropenem, Fosfomycin, Imipenem, Ertapenem, Piperacillin-tazobactam, Nitrofurantoin, Gentamicin and Tobramycin, whereas showed moderate sensitivity towards Norfloxacin, Ciprofloxacin, Cefepime, Cefazolin, Ceftazidime, Ceftriaxone, Aztreonam and Trimethoprimsulfamethoxazole and showed low sensitivity towards Amoxycillin-clavulinic acid and Ampicillin.
Similar pattern of antibiotic sensitivity was also shown by Elzayat MAA et al, Shaifali I et al, Gupta K et al and Kumari A et al. 3, 8, 9, 14 In case of ESBL producers, the overall sensitivity decreases except Amikacin, Tigecycline, Carbapenems and Piperacillin-tazobactam.
In case of non-β-lactam antibiotics the sensitivity decreases in ESBL producer strains which may be due to transfer of resistance genes for these non-β-lactam antibiotics along with ESBL resistance marker. Such type of coexistence of ESBL producer and other non-β-lactam antibiotic resistance marker was reported by Babypadmini S et al, as ESBLs are encoded by plasmids, which carry resistance genes for other antibiotics also. 6 The evaluation of multidrug resistance pattern showed that 50% of all the isolates were MDR and most of the isolates were resistant to more than 5 drug groups while only 22.2% of isolates were sensitive to all the drug groups. All the ESBL producer isolates were MDR. Similar pattern of multidrug resistance was also showed by Mukherjee M et al. 15 The correlation of ESBL producer and MDR in this study closely resembles the study conducted by Raijini CY et al. 7 The first line of antibiotic for treatment of uncomplicated urinary tract infection in females is Trimethoprimsulfamethoxazole while in second line it is fluoroquinolones. 16 There are reports of increasing resistance of Ciprofloxacin and Trimethoprimsulfamethoxazole over the years due to overuse of these antibiotics and treatment failure with Trimethoprimsulfamethoxazole in areas with high prevalence of resistance with this antibiotic has been reported. 17, 18 Study conducted by Gobernado M et al found Fosfomycin as the best drug against Escherichia coli in uncomplicated cystitis. 19 Infectious Disease Society of America (IDSA) (2010 update) recommends Nitrofurantoin as the first choice followed by Trimethoprim-sulfamethoxazole, Fosfomycin etc. 20 Nitrofurantoin has shown very low level of resistance but may cause birth defects and should be cautiously used. 21 Patients infected with ESBL producer Escherichia coli strains, cannot be treated with β-lactam antibiotics and monobactams. 6 As in our study high sensitivity was shown by Amikacin, Nitrofurantoin and Fosfomycin, these antibiotics can be used as alternatives for emperical treatment of such patients at low cost, as Nitrofurantoin and Fosfomycin are available in oral form, provided Nitrofurantoin is cautiously used in pregnant women. Also measures to be taken to preserve higher end antibiotics like carbapenems and Piperacillin-tazobactam and should be used only in non-responsive cases.
CONCLUSION
In this study Escherichia coli was the predominant uropathogen isolated from female patients and mostly resistant to commonly prescribed drugs and clinicians are left with very few alternative drugs.
The antimicrobial resistance pattern showed that fluoroquinolones or cephalosporins may not be appropriate first line agents in empirical treatment of urinary tract infections. Instead Amikacin, Nitrofurantoin and Fosfomycin can be used as first line drug, out of which Amikacin is available in injectable form and Nitrofurantoin and Fosfomycin available as oral antibiotic.
